{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:40:38Z","timestamp":1794357638404,"version":"4.9.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.surg.2021.03.046","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T05:09:30Z","timestamp":1619240970000},"page":"1205-1214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"170","author":[{"given":"Nguyen-Phong","family":"Vo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2963-6702","authenticated-orcid":false,"given":"Hung Song","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9346-6886","authenticated-orcid":false,"given":"El-Wui","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-834X","authenticated-orcid":false,"given":"Ka-Wai","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2021.03.046_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/jso.21374","article-title":"Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program","volume":"100","author":"Albores-Saavedra","year":"2009","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jso.25336","article-title":"Incidence and comparative outcomes of periampullary cancer: a population-based analysis demonstrating improved outcomes and increased use of adjuvant therapy from 2004 to 2012","volume":"119","author":"Hester","year":"2019","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib3","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1245\/s10434-015-4499-y","article-title":"Substaging nodal status in ampullary carcinomas has significant prognostic value: proposed revised staging based on an analysis of 313 well-characterized cases","volume":"22","author":"Balci","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/SLA.0000000000003177","article-title":"Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: international multicenter cohort study","volume":"272","author":"Moekotte","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamasurg.2019.1170","article-title":"Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma","volume":"154","author":"Ecker","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00000658-199511000-00005","article-title":"Clinical behavior and prognostic factors of periampullary adenocarcinoma","volume":"222","author":"Chan","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2012.7352","article-title":"Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial","volume":"308","author":"Neoptolemos","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.surg.2021.03.046_bib8","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/SLA.0b013e318190c53e","article-title":"Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial","volume":"248","author":"Morak","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib9","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2021.03.046_bib10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00000658-199912000-00006","article-title":"Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group","volume":"230","author":"Klinkenbijl","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.surg.2021.03.046_bib12","first-page":"33","article-title":"Patterns of failure after pancreaticoduodenectomy for ampullary carcinoma","volume":"176","author":"Willett","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.surg.2021.03.046_bib13","series-title":"The NCI Dictionary of Cancer Terms","year":"2020"},{"key":"10.1016\/j.surg.2021.03.046_bib14","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.surg.2021.03.046_bib15","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.surg.2021.03.046_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.surg.2021.03.046_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.surg.2021.03.046_bib18","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.surg.2021.03.046_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/jso.25808","article-title":"Impact of adjuvant chemotherapy regimen on survival outcomes in immunohistochemical subtypes of ampullary carcinoma","volume":"121","author":"Al Abbas","year":"2020","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.pan.2020.01.009","article-title":"Adjuvant therapy is associated with improved overall survival in patients with pancreatobiliary or mixed subtype ampullary cancer after pancreatoduodenectomy: a multicenter cohort study","volume":"20","author":"Bolm","year":"2020","journal-title":"Pancreatology"},{"key":"10.1016\/j.surg.2021.03.046_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.pan.2019.01.019","article-title":"Clinical relevance of pancreatobiliary and intestinal subtypes of ampullary and duodenal adenocarcinoma: pattern of recurrence, chemotherapy, and survival after pancreatoduodenectomy","volume":"19","author":"Bowitz Lothe","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.surg.2021.03.046_bib22","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.amjsurg.2017.01.029","article-title":"Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma","volume":"214","author":"Chavez","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00259-014-2907-3","article-title":"Prognostic significance of standardized uptake value on preoperative (1)(8)F-FDG PET\/CT in patients with ampullary adenocarcinoma","volume":"42","author":"Choi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.surg.2021.03.046_bib24","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/MPA.0000000000000929","article-title":"Development of a prognostic model that predicts survival after pancreaticoduodenectomy for ampullary cancer","volume":"46","author":"Feretis","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.surg.2021.03.046_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151406","article-title":"Survival outcomes according to adjuvant treatment and prognostic factors including host immune markers in patients with curatively resected ampulla of vater cancer","volume":"11","author":"Ha","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.046_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ejso.2018.02.008","article-title":"Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience","volume":"44","author":"Jin","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijrobp.2008.11.067","article-title":"Role of adjuvant chemoradiotherapy for ampulla of vater cancer","volume":"75","author":"Kim","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.surg.2021.03.046_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ejso.2011.06.008","article-title":"Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience","volume":"37","author":"Lazaryan","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib29","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0360-3016(00)00537-X","article-title":"Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas","volume":"47","author":"Lee","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.surg.2021.03.046_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12957-019-1675-8","article-title":"High-Mobility Group Box 1 expression predicts survival of patients after resection of adenocarcinoma of the ampulla of Vater","volume":"17","author":"Murakami","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1748-717X-6-126","article-title":"Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study","volume":"6","author":"Narang","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib32","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.18_suppl.lba4006","article-title":"Ampullary cancer ESPAC-3 (v2) trial: a multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater","volume":"29","author":"Neoptolemos","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib33","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.hpb.2019.07.006","article-title":"Clinico-pathological correlates and survival outcomes in 214 resected ampullary adenocarcinomas: are outcomes different in intestinal and pancreatobiliary subtypes with adjuvant gemcitabine?","volume":"22","author":"Ramaswamy","year":"2020","journal-title":"HPB"},{"key":"10.1016\/j.surg.2021.03.046_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.surg.2015.02.001","article-title":"Histomorphologic and molecular phenotypes predict gemcitabine response and overall survival in adenocarcinoma of the ampulla of Vater","volume":"158","author":"Schiergens","year":"2015","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2021.03.046_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.suronc.2019.02.006","article-title":"Role of systemic inflammation in predicting the prognosis of ampulla of Vater carcinoma","volume":"29","author":"Seo","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib36","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s11605-011-1518-6","article-title":"The influence of prognostic factors and adjuvant chemoradiation on survival after pancreaticoduodenectomy for ampullary carcinoma","volume":"15","author":"Showalter","year":"2011","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejso.2004.08.013","article-title":"Adjuvant chemo-radiotherapy in ampullary cancers","volume":"31","author":"Sikora","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229597","article-title":"Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer","volume":"15","author":"Yoo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2021.03.046_bib39","first-page":"421","article-title":"Patterns of failure for stage I ampulla of Vater adenocarcinoma: a single institutional experience","volume":"5","author":"Zhong","year":"2014","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib40","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s13277-013-1153-9","article-title":"Prognostic factors of carcinoma of the ampulla of Vater after surgery","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.surg.2021.03.046_bib41","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/bjs.10563","article-title":"Meta-analysis of adjuvant therapy following curative surgery for periampullary adenocarcinoma","volume":"104","author":"Acharya","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/SLA.0000000000001182","article-title":"Survival benefit of adjuvant chemoradiotherapy in patients with ampulla of vater cancer: a systematic review and meta-analysis","volume":"262","author":"Kwon","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2021.03.046_bib43","unstructured":"Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Oncology Center of Excellence. Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Guidance for Industry Food and Drug Administration (FDA);\u00a02018."},{"key":"10.1016\/j.surg.2021.03.046_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S1470-2045(13)70388-7","article-title":"Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis","volume":"14","author":"Liao","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib45","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJM200006223422507","article-title":"Randomized, controlled trials, observational studies, and the hierarchy of research designs","volume":"342","author":"Concato","year":"2000","journal-title":"NEJM"},{"key":"10.1016\/j.surg.2021.03.046_bib46","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s11605-017-3624-6","article-title":"Association of adjuvant therapy with improved survival in ampullary cancer: a national cohort study","volume":"22","author":"Nassour","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib47","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/jso.25021","article-title":"Ampullary adenocarcinoma: defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease","volume":"117","author":"Stiles","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib48","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant therapy for resected biliary\u00a0tract cancer: ASCO clinical practice guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.surg.2021.03.046_bib49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/MPA.0000000000000112","article-title":"Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study","volume":"43","author":"Robert","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.surg.2021.03.046_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pan.2017.01.007","article-title":"The histopathologic type predicts survival of patients with ampullary carcinoma after resection: a meta-analysis","volume":"17","author":"Zhou","year":"2017","journal-title":"Pancreatology"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606021002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606021002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:58:05Z","timestamp":1758538685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606021002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0039606021002439"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2021.03.046","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of adjuvant therapy after curative surgery for ampullary carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2021.03.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}